Here's the latest news from Santéand its portfolio companies
Portfolio
Solu Therapeutics Initiates Dosing in Acute Myeloid Leukemia Cohort of the Ongoing Phase 1 Study of STX-0712
Portfolio
Kestrel Therapeutics Announces IND Clearance by U.S. FDA of KST-6051, a Potential Best-in-Class Pan-KRAS Inhibitor, Enabling Initiation of Phase 1 Trial
Portfolio
ABK Biomedical Completes Enrollment in ROUTE90 Pivotal Study for Primary Liver Cancer
Santé
Three Healthcare VCs That Are Beating a Tough Fundraising Market
Portfolio
beHuman Raises $4 Million Seed Round to Expand Equitable, AI-Driven Early Cancer Detection Nationwide
Portfolio
Graici leading the way in Medicaid Renewal and Redetermination Secures $7.5 Million Series A Led by Santé Ventures
Santé
Santé Ventures Raises $330 Million for Fifth Fund to Advance Breakthrough Healthcare Innovation
Portfolio
Brado forms new AI health care company after landing investment from Santé Ventures
Portfolio
Clairity Appoints Founder Dr. Connie Lehman as Chief Executive Officer
Portfolio
Brado and Santé Ventures Partner to Transform Patient Navigation and Engagement
Portfolio
Reimagine Care and Tampa General Hospital Cancer Institute Launch Virtual Cancer Care Collaboration to Reduce Hospitalizations and Elevate Patient Support
Portfolio
Solu Therapeutics Announces Presentation of Trial in Progress on STX-0712 for Treatment of Chronic Myelomonocytic Leukemia and Acute Myeloid Leukemia at ASH Annual Meeting
Portfolio
Clairity, Myriad Genetics, and MagView Launch the First Integrated AI and Genetic Risk Platform for Personalized Breast Health
Portfolio
Clairity Raises $43 Million in Series B to Launch First FDA-Authorized AI Platform for Breast Cancer Risk Prediction
Portfolio
Digital Mental Health Coaching in Clinically Diverse Populations: Controlled Engagement and Outcomes Study
Portfolio
FARAPULSE™ PFA PLATFORM Team Wins Inaugural Thomas J. Fogarty Innovation Prize
